Publication | Closed Access
Prolonged Hemodynamic Maintenance by the Combined Administration of Vasopressin and Epinephrine in Brain Death: A Clinical Study
139
Citations
0
References
1986
Year
HypertensionHeart FailureBrain DeathHead InjuryPrehospital ResuscitationCerebral Vascular RegulationCardiopulmonary ResuscitationHemodynamic MaintenanceSynthetic Arginine VasopressinIntracranial PressureBrain InjuryNeurologyCerebral Blood FlowReperfusion InjuryCardiac ArrestCritical Care ManagementCardiovascular DiseaseNeurophysiologyCombined AdministrationAnesthesiaMedicineEmergency Medicine
The present study attempted long term hemodynamic maintenance in 16 adult brain-dead patients, 14 with head injury and 2 with cerebrovascular accidents. In addition to respiratory and fluid management, 10 were treated with continuous infusion of epinephrine to maintain systolic blood pressure above 90 mm Hg. The remaining 6 patients each received a continuous infusion of synthetic arginine vasopressin (ADH) at a rate of 1 or 2 units/hour (285 +/- 45 microunits/kg/minute) simultaneously with epinephrine. The 10 patients treated with epinephrine alone all succumbed to cardiac arrest within 48 hours of brain death, with a mean survival time of 24.1 +/- 17.2 hours. In the patients who received simultaneous ADH infusion, a minimal dose of epinephrine of no more than 0.5 mg/hr in most instances sufficed to maintain blood pressure. Their mean survival time after brain death was remarkably prolonged to 23.1 +/- 19.1 days. In brain death, ADH plays a critical role in hemodynamic maintenance, and ADH administration permits long term hemodynamic stabilization of brain-death patients, offering increasing opportunities for organ transplantation.